Securities Code: 301130
Securities Abbreviation: Xidian Pharmaceutical
Announcement No.: 2026-059
Jilin Xidian Pharmaceutical Technology Development Co., Ltd.
Announcement on the Completion of Board of Directors Election and Appointment of Senior Management and Other Personnel
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Jilin Xidian Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as the "Company") convened its 2026 Second Extraordinary Shareholders' Meeting on July 30, 2026, in accordance with the relevant provisions of the "Company Law" and the "Articles of Association." The meeting elected 5 non-independent directors and 3 independent directors for the Ninth Board of Directors. Together with the 1 employee representative director elected at the 2026 First Employee Representative Congress held on July 30, 2026, the Ninth Board of Directors was formed. The term of the Ninth Board of Directors shall be three years from the date of deliberation and approval by the 2026 Second Extraordinary Shareholders' Meeting and the 2026 First Employee Representative Congress.
On July 30, 2026, the Company held the First Meeting of the Ninth Board of Directors, at which the Chairman, members of the specialized committees of the Board of Directors were elected, and new senior management personnel, the Securities Affairs Representative, and the head of the Internal Audit Department were appointed. The election and appointment process for the Board of Directors has been completed, and the relevant information is hereby announced as follows:
I. Composition of the Ninth Board of Directors
The Ninth Board of Directors consists of 9 directors, including 5 non-independent directors, 3 independent directors, and 1 employee representative director. The specific members are as follows:
Non-independent Directors: Mr. Zhang Jun (Chairman), Ms. Zhang Yinji, Mr. Meng Si, Mr. Shen Taigen, Mr. Wang Zhifeng
Independent Directors: Mr. Lu Xiangjun (Accounting Professional), Ms. Wu Nannan, Mr. Li Jianxin
Employee Representative Director: Mr. Wu Jiajia
The number of members of the Ninth Board of Directors who concurrently hold senior management positions in the Company and directors appointed as employee representatives does not exceed one-half of the total number of directors of the Company. The qualifications and independence of the 3 independent directors
In the 2026 Second Extraordinary Shareholders' Meeting, the independent director ratio did not fall below one-third of the total number of directors. The number of independent directors serving concurrently as independent directors of domestic listed companies did not exceed three, nor were there any instances of independent directors serving for more than six years, which complies with relevant laws, regulations, and normative documents.
The resumes of the above-mentioned directors can be found in the "Announcement on the Election of the Board of Directors" disclosed by the Company on the Juchao Information Network (www.cninfo.com.cn) on July 14, 2026, and the "Announcement on the Election of the Employee Representative Director of the Ninth Board of Directors" disclosed by the Company on the Juchao Information Network (www.cninfo.com.cn) on July 30, 2026.
II. Composition of the Specialized Committees of the Ninth Board of Directors
- Strategy and Sustainable Development Committee (3 members)
Members: Mr. Zhang Jun (Chairman), Ms. Zhang Yinji, Mr. Li Jianxin
- Audit Committee (3 members)
Members: Mr. Lu Xiangjun (Chairman), Ms. Wu Nannan, Mr. Wang Zhifeng
- Nomination Committee (3 members)
Members: Mr. Li Jianxin (Chairman), Mr. Lu Xiangjun, Mr. Meng Si
- Remuneration and Appraisal Committee (3 members)
Members: Ms. Wu Nannan (Chairman), Mr. Li Jianxin, Mr. Meng Si